R688-AD-1434: AN OPEN-LABEL EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN PATIENTS ?6 MONTHS TO <18 YEARS OF AGE WITH ATOPIC DERMATITIS R688-AD-1434

Project: Research project

Project Details

StatusFinished
Effective start/end date2/1/1810/31/23

Funding

  • Northwestern University
  • Regeneron Pharmaceuticals, Inc.